Physician profile
Michael King
NPI 1326153339
$190,479.39
in general payments reported to CMS, 2019-2025
12 companies · $37.19 in 2025
The $37.19 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,275 · 2020: $648 · 2021: $2,313 · 2022: $30K · 2023: $91K · 2024: $63K · 2025: $37.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $102K · Travel and Lodging: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $3,115 · Consulting Fee: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $101,715.00 |
| Travel and Lodging | $32,375.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,654.69 |
| Food and Beverage | $3,114.57 |
| Consulting Fee | $1,660.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $153,354.08 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $29,445.36 | 2022 | |
| Modulated Imaging, INC. | $5,448.63 | 2019-2021 | |
| Heron Therapeutics, INC. | $1,520.50 | 2021 | |
| Organogenesis INC. | $485.40 | 2021-2022 | |
| Smith+Nephew, INC. | $65.55 | 2022-2023 | Renasys Go V2 Home, Pico 14 |
| Boston Scientific Corporation | $37.85 | 2024 | Autotome Rx 49 |
| Collaborative Care Diagnostics, LLC | $36.49 | 2024 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Kerecis Limited | $25.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Siemens Medical Solutions USA, INC. | $16.27 | 2025 | Artis Icono Biplane |
| Stryker Corporation | $14.71 | 2024 | Salvation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.